Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 16/20 | 0.69 |
| ▸ | CA1 | P00915 | 15/20 | 0.69 |
| ▸ | CA2 | P00918 | 15/20 | 0.69 |
| ▸ | CA12 | O43570 | 6/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | CA7 | P43166 | 2/20 | 0.60 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.55 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.55 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17971092 | 0.94 | DNASE1L3 (0.63) | CA9CA1CA2CA12USP2 | |
| SCHEMBL12231957 | 0.90 | CA9 (0.72) | CA9CA1CA2CA12USP2 | |
| SCHEMBL15828111 | 0.89 | CA9 (0.83) | CA9CA1CA2CA12USP2 | |
| SCHEMBL19818216 | 0.89 | CA9 (0.72) | CA9CA1CA2CA12USP2 | |
| SCHEMBL13097493 | 0.88 | CA9 (0.75) | CA9CA1CA2CA12USP2 | |
| SCHEMBL2234764 | 0.88 | CA9 (0.83) | CA9CA1CA2CA12USP2 | |
| SCHEMBL12060447 | 0.88 | CA9 (0.75) | CA9CA1CA2CA12USP2 | |
| SCHEMBL19954964 | 0.88 | CA9 (0.72) | CA9CA1CA2CA12USP2 | |
| SCHEMBL14086339 | 0.87 | CA9 (0.69) | CA9CA1CA2CA12USP2 | |
| SCHEMBL12060571 | 0.87 | CA9 (0.69) | CA9CA1CA2CA12USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220402963-A1 | NUCLEOTIDE PROBES | Sony Group Corporation (JP) | 2022-12-22 | — | — | US | disclosed |
| US-11352502-B2 | Polymeric tandem dyes with linker groups | Sony Group Corporation (JP) | 2022-06-07 | — | — | US | disclosed |
| US-20210253864-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | Sony Group Corporation (JP) | 2021-08-19 | — | — | US | disclosed |
| US-9889213-B2 | Multimodal imaging of fibrin | THE GENERAL HOSPITAL CORPORATION (US) | 2018-02-13 | — | — | US | disclosed |
| US-20080234464-A1 | Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same | CREDIA JAPAN CO., LTD. (JP) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402963-A1 | NUCLEOTIDE PROBES | METTL3, SNRPA, L3MBTL3 | CA9 3084/4885CA1 2529/4885CA2 3225/4885 |
| US-11352502-B2 | Polymeric tandem dyes with linker groups | CHRM1, IK, TMT1A | CA9 3382/4885CA1 886/4885CA2 2535/4885 |
| US-20080234464-A1 | Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same | NGLY1, ELOVL6, ELOVL1 | CA9 2059/4885CA1 1005/4885CA2 2507/4885 |
| US-20210253864-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | CHRM1, IK, TMT1A | CA9 3382/4885CA1 886/4885CA2 2535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.